On April 23, 2025, the U.S. Food and Drug Administration (FDA) granted approval to Akeso Biopharma Co., Ltd.’s penpulimab-kcqx for the first-line treatment of adults with recurrent or metastatic ...

Shares of Autodesk gained 2.5% on Thursday after the company and activist investor Starboard Value reached a deal to place ...